Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
By J. Wrammert, Kenneth Smith, Joseph I. Miller, William A. Langley, K. Kokko, Christian Larsen, Nai-Ying Zheng, I. Mays, Lori Garman, Christina Helms and 5 more. Nature, 2008
1,029 citations recorded by the source corpus.
Subfields: Epidemiology, Immunology
View Paper: https://www.semanticscholar.org/paper/4af23a5b2d097ccd38e1ae1a989729b27e0b2aac
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- F. Krammer
- A. García‐Sastre
- P. Palese
- Barney S. Graham
- F. Sallusto
- Rafi Ahmed
- Yi Guan
- Jacques Banchereau
In Immunology
- Jacques Banchereau
- Rafi Ahmed
- Bali Pulendran
- F. Sallusto
- A. Lanzavecchia
- K. Araki
- V. Pascual
- A. Palucka
Citations in the corpus
- Generation of stable monoclonal antibody-producing BCR+ human memory B cells by genetic programming (2009, result): “The fact that rare B cells can easily be cloned compares our method favorably with a recently described single-cell cloning approach used to isolate influenza-specific antibodie”
- From Vaccines to Memory and Back (2010, positive): “…followed by selection with functional assays (Traggiai et al., 2004), or by isolation of antigen-binding memory B cells or of total plasma cells followed by rescue of the specific antibodies by single cell PCR and expression in heterologous systems (Scheid et al., 2009; Wrammert et al., 2008).”
- Standardizing immunophenotyping for the Human Immunology Project (2012, background): “Plasmablasts — the activated (CD38 + ) subset of antibody-secreting B cells — have been shown to increase in number post-vaccinatio”
- Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination (2013, background): “Nonetheless, it is intriguing that the emergence of plasmablasts and ICOSCXCR3CXCR5CD4 T cells in blood peaks at the same time after influenza vaccination (at day 7) (33).”
- Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans (2014, methodology): “HA-specific ELISA, as well as HAI (done with the chimeric H9N3 virus) were performed as previously described (40).”
- Systems Biology of Seasonal Influenza Vaccination in Humans (2011, methodology): “Since the frequencies of plasmablasts return to barely detectable numbers by day 14 post-vaccination 15 , this correlation suggests that the later antibody response is associated with early circulation of plasmablasts in the blood of vaccinees 3 .”
- Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells (2008, background): “However it has long been known that the immune response against influenza virus is highly restricted [15], as borne out by a recent cloning study [16], and focused on subtype and strain specific epitopes [17,18].”
- Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors (2016, positive): “This result is in stark contrast to the relatively restricted repertoires observed in HIVinfected patients (31) or in healthy donors after influenza vaccination (32).”
- Antibody landscapes after influenza virus infection or vaccination (2014, neutral): “The presence of higher preexposure static titers, but not higher dynamic responses, to the first infecting strain may explain seemingly contradictory reports whereby cross-sectional studies have tended to describe a serological bias supportive of the original antigenic sin dogma (5, 11) while invest”